Bora Plants Its Flag in the US with $210M Acquisition of Generics Manufacturer Upsher-Smith

Taiwan-based CDMO Bora Pharmaceuticals is expanding its business in the United States, acquiring Minnesota generics manufacturer Upsher-Smith Laboratories for $210 million. Upsher-Smith, which was established in 1919, brings two manufacturing facilities that are five miles apart in the suburbs of Minneapolis. These become Bora’s first facilities in the U.S. Bora also has a 170,000 square meter plant in Mississauga, Ontario, which acts as its North America headquarters. Upsher-Smith produces a portfolio of 48 generic products. Its plants can handle packaging and a range of formulations including oral solids, liquids and topical powders. The sites have a total annual capacity of 3.5 billion doses.

Read the full article: Bora Plants Its Flag in the US with $210M Acquisition of Generics Manufacturer Upsher-Smith //

Source: https://www.fiercepharma.com/manufacturing/bora-plants-its-flag-us-210m-acquisition-generics-manufacturer-upsher-smith

Leave a Comment

Your email address will not be published.

Scroll to Top